# Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)

> **NCT01075711** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 2728 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01075711
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 2728 (ACTUAL)
- **Last updated:** 2014-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01075711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01075711, "Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01075711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*